The EC has approved Incyte’s Minjuvi (tafasitamab) with lenalidomide and rituximab for adults with relapsed or refractory FL.

Core active pharmaceutical ingredients (APIs) such as penicillins, streptomyces, tetracyclines, and erythromycins also get ...

The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY ® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult ...

PRESS RELEASE Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union Orphan designation confers ...

With the acceptance of international GMP standards and duty-free certainty for key APIs, India is poised to strengthen its ...

Sanofi gains EMA Orphan Drug status for efdoralprin alfa, a phase II biologic for AATD-related emphysema with promising dosing data.

The field of Regulatory science ensures that medicines, vaccines, and health products are safe and effective for people to ...

Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a ...

The EU is set to introduce new incentives to stimulate pharmaceutical R&D, particularly for new antibiotics and treatments ...

India gains duty-free access for medicines & vaccines in Oman under CEPA. Fast-track approvals & GMP acceptance to boost ...

ImmunityBio Inc. (NASDAQ:IBRX) is one of the best multibagger penny stocks to buy right now. On December 12, analysts at ...

A study by CIC biomaGUNE and Biogipuzkoa HRI conducted on mice has found that the prolonged intake of sweeteners may exert ...